Next Article in Journal
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington’s Disease Patients—A Randomized Phase 2 Clinical Trial
Previous Article in Journal
Advances in Molecular Imaging and Radionuclide Therapy of Neuroendocrine Tumors
 
 
Article

Article Versions Notes

J. Clin. Med. 2020, 9(11), 3681; https://doi.org/10.3390/jcm9113681
Action Date Notes Link
article pdf uploaded. 16 November 2020 16:01 CET Version of Record https://www.mdpi.com/2077-0383/9/11/3681/pdf-vor
article xml file uploaded 17 November 2020 07:22 CET Original file -
article xml uploaded. 17 November 2020 07:22 CET Update https://www.mdpi.com/2077-0383/9/11/3681/xml
article pdf uploaded. 17 November 2020 07:22 CET Updated version of record https://www.mdpi.com/2077-0383/9/11/3681/pdf
article html file updated 17 November 2020 07:24 CET Original file -
article html file updated 23 July 2022 01:18 CEST Update https://www.mdpi.com/2077-0383/9/11/3681/html
Back to TopTop